What is DnaNudge?
Founded in 2015, DnaNudge operates at the intersection of biotechnology and consumer health. The company specializes in advanced DNA testing, specifically targeting the management and prevention of hypertension, cholesterol, and type two diabetes. By providing actionable, genetic-based insights, DnaNudge enables users to make informed lifestyle choices that directly impact their metabolic health. The company's unique market position is defined by its ability to translate complex genetic data into simple, daily health interventions, effectively bridging the gap between clinical research and everyday wellness. As a leader in the UK health-tech ecosystem, DnaNudge continues to refine its diagnostic tools to address the growing global burden of chronic lifestyle-related diseases.
How much funding has DnaNudge raised?
DnaNudge has raised a total of $60M across 1 funding round:
Series A
$60M
Series A (2021): $60M with participation from Ventura Capital and Bank Julius Baer
Key Investors in DnaNudge
Ventura Capital
A venture capital firm focused on identifying and scaling high-growth technology companies with significant market disruption potential.
Bank Julius Baer
A leading Swiss private banking group that provides strategic financial backing to innovative enterprises and high-growth ventures.
What's next for DnaNudge?
With the successful closure of this major strategic investment, DnaNudge is poised to enter a new phase of enterprise-level growth. The company is expected to prioritize the expansion of its clinical research initiatives and the broader commercialization of its diagnostic platform. Future strategic efforts will likely focus on integrating its genetic testing technology into wider healthcare networks and enhancing its digital infrastructure to support a larger user base. By maintaining a rigorous focus on scientific validation and technological innovation, DnaNudge is well-positioned to disrupt traditional approaches to chronic disease management, ultimately aiming to improve long-term health outcomes through precision-based, data-driven interventions.
See full DnaNudge company page
